BlackRock’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.93M Buy
228,767
+14,893
+7% +$306K ﹤0.01% 3926
2025
Q4
$4.99M Sell
213,874
-21,414
-9% -$553K ﹤0.01% 3840
2025
Q3
$7.47M Sell
235,288
-8,207
-3% -$248K ﹤0.01% 3598
2025
Q2
$6.91M Buy
243,495
+32,429
+15% +$972K ﹤0.01% 3603
2025
Q1
$6.52M Sell
211,066
-3,933
-2% -$134K ﹤0.01% 3525
2024
Q4
$7.14M Buy
214,999
+8,137
+4% +$276K ﹤0.01% 3582
2024
Q3
$6.26M Buy
206,862
+9,845
+5% +$307K ﹤0.01% 3614
2024
Q2
$5.56M Sell
197,017
-570
-0.3% -$17.9K ﹤0.01% 3651
2024
Q1
$7.31M Sell
197,587
-7,158
-3% -$268K ﹤0.01% 3517
2023
Q4
$8.42M Buy
204,745
+23,842
+13% +$765K ﹤0.01% 3482
2023
Q3
$5.63M Buy
180,903
+8,479
+5% +$328K ﹤0.01% 3612
2023
Q2
$6.91M Buy
172,424
+163,806
+1,901% +$6.7M ﹤0.01% 3582
2023
Q1
$355K Buy
8,618
+493
+6% +$20.8K ﹤0.01% 4627
2022
Q4
$370K Buy
8,125
+586
+8% +$20.2K ﹤0.01% 4691
2022
Q3
$224K Sell
7,539
-274
-4% -$7.67K ﹤0.01% 4949
2022
Q2
$163K Sell
7,813
-128
-2% -$2.99K ﹤0.01% 5096
2022
Q1
$226K Sell
7,941
-387
-5% -$9.82K ﹤0.01% 5077
2021
Q4
$247K Buy
8,328
+301
+4% +$9.47K ﹤0.01% 5061
2021
Q3
$276K Sell
8,027
-172
-2% -$6.17K ﹤0.01% 4906
2021
Q2
$303K Buy
+8,199
New +$240K ﹤0.01% 4804

Other funds holding SMTI

BlackRock's SMTI Position: Q1 2026 in Review

BlackRock increased its Sanara MedTech (SMTI) stake by 7% in Q1 2026, buying an estimated $306K and bringing the position to 228,767 shares worth $3.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3926.

BlackRock first reported a position in SMTI in Q2 2021 and has held it in 20 quarters since. The position peaked at $8.42M in Q4 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • BlackRock held 228,767 shares of Sanara MedTech worth $3.93M as of Q1 2026.
  • BlackRock bought 14,893 Sanara MedTech shares in Q1 2026, an estimated $306K.
  • Sanara MedTech made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3926 holding.
  • BlackRock first reported a position in Sanara MedTech in Q2 2021 and has held it in 20 quarters since.
  • BlackRock's Sanara MedTech position peaked at $8.42M in Q4 2023.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.